Inventor · disambiguated record
Per Thor Straten
Also filed as: STRATEN PER THOR
8 granted patents·4 pending applications·21 citations·filing 2004–2025
83Inventor score
Top patents by PatentIndex Score
12 records- 0191US11648302B2Indoleamine 2,3-dioxygenase based immunotherapyIO BIOTECH APS·Filed 2022·Granted May 16, 2023·1 cites·19 claims
- 0285US12233103B2Indoleamine 2,3-dioxygenase based immunotherapyIO BIOTECH APS·Filed 2023·Granted Feb 25, 2025·0 cites·19 claims
- 0385US11324813B2Indoleamine 2,3-dioxygenase based immunotherapyIO BIOTECH APS·Filed 2019·Granted May 10, 2022·1 cites·18 claims
- 0483US9433666B2Indoleamine 2,3-dioxygenase based immunotherapyANDERSEN MADS HALD·Filed 2009·Granted Sep 6, 2016·4 cites·2 claims
- 0578US2022202922A1Indoleamine 2,3-dioxygenase based immunotherapyIO BIOTECH APS·Filed 2022·Application pending·0 cites
- 0676US7842294B2Proteins belonging to the Bcl-2 family and fragments thereof, and their use in cancer patientsSURVAC APS·Filed 2004·Granted Nov 30, 2010·10 cites·53 claims
- 0775US10258678B2Indoleamine 2,3-dioxygenase based immunotherapyIO BIOTECH APS·Filed 2016·Granted Apr 16, 2019·1 cites·13 claims
- 0875US2025319159A1Indoleamine 2,3-dioxygenase based immunotherapyIO BIOTECH APS·Filed 2025·Application pending·0 cites
- 0972US7687465B2Therapeutic cancer vaccineSURVAC APS·Filed 2004·Granted Mar 30, 2010·4 cites·9 claims
- 1066US2019247480A1RhoC-Based ImmunotherapyRHOVAC APS·Filed 2019·Application pending·0 cites
- 1162US9163077B2RhoC-based immunotherapyANDERSEN MADS HALD·Filed 2008·Granted Oct 20, 2015·0 cites·15 claims
- 1246US2016008448A1Rhoc-based immunotherapyRHOVAC APS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Per Thor Straten files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →